Organization Announcements

Editor’s Note:

Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.

Airfinity    [to  30 Apr 2022]

https://www.airfinity.com/insights

INSIGHTS & COMPANY NEWS

Global sales estimate for COVID-19 antiviral pills increased by 60% to $32.5bn

Published by Airfinity

Apr 21, 2022

   Airfinity has released its latest COVID-19 treatments revenue forecast for Q1 2022 and 2022.

Paul G. Allen Frontiers Group    [to  30 Apr 2022]

https://alleninstitute.org/news-press/

News

News from the Allen Institute: April 2022

April 28, 2022

   Highlights include: a new Lab Notes podcast on why we don’t understand the brain, new research about how neurons connect, day-in-the-life features of our neuroscience labs and more. 

BMGF – Gates Foundation  [to  30 Apr 2022]

https://www.gatesfoundation.org/ideas/media-center

Press Releases and Statements

No new digest content identified.

Bill & Melinda Gates Medical Research Institute    [to  30 Apr 2022]

https://www.gatesmri.org/news

The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people

No new digest content identified.

CARB-X   [to  30 Apr 2022]

Home

News

No new digest content identified.

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation   [to  30 Apr 2022]

https://centerforvaccineethicsandpolicy.net/

News/Analysis/Statements

:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.

:: Informed Consent: A Monthly Review – April 2022is now posted here

:: Statement on ICF [Informed Consent Form] Posting for Clinical Trials Involving Gene Editing/Gene Therapies – Invitation to Endorse

:: Patients, Politics, Pressure :: Pharma Stays Steady [Mostly] In Russia Sanctions Context

Observations at 30 March 2022     David R Curry

CEPI – Coalition for Epidemic Preparedness Innovations  [to  30 Apr 2022]

http://cepi.net/

Latest News

No new digest content identified.

DARPA – Defense Advanced Research Projects Agency [U.S.] [to  30 Apr 2022

https://www.darpa.mil/news

News

No new digest content identified.

Duke Global Health Innovation Center  [to  30 Apr 2022]

Home

Our Blog

No new digest content identified.

EDCTP    [to  30 Apr 2022]

http://www.edctp.org/

The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials

News

29 April 2022

Belgium and Côte d’Ivoire join EDCTP Association

25 April 2022

World Malaria Day 2022: EDCTP supports innovative approaches to fight malaria

Emory Vaccine Center    [to  30 Apr 2022]

http://www.vaccines.emory.edu/

Vaccine Center News

Emory/Georgia funded TRAC by NIAID

NIH Funds New Tuberculosis Research Advancement Centers

European Vaccine Initiative  [to  30 Apr 2022]

http://www.euvaccine.eu/

Latest News, Events

“Vaccines provide everyone a chance at a fulfilling life”

World Immunization Week: 24 – 30 April 2022

Evidence Aid   [to  30 Apr 2022]

Evidence Aid aims to save lives and livelihoods in disasters by providing decision-makers with the best available evidence and by championing its use.

http://www.evidenceaid.org/

New Resources

Prophylactic anticoagulants for hospitalized COVID‐19 patients (search up to 14 April 2021) Added April 25, 2022

Fondation Merieux  [to  30 Apr 2022]

http://www.fondation-merieux.org/

News, Events 

Mérieux Foundation & University of Geneva co-organized event

22nd Advanced Vaccinology Course (ADVAC)

May 9 – 20, 2022 – Les Pensières Center for Global Health, Veyrier-du-Lac (France)

Gavi [to  30 Apr 2022]

https://www.gavi.org/

News Releases

27 April 2022

Amref health Africa appointed by Gavi as the new Civil Society Organisation (CSO) host

GHIT Fund   [to  30 Apr 2022]

https://www.ghitfund.org/newsroom/press

Press Releases

No new digest content identified.

Global Fund  [to  30 Apr 2022]

https://www.theglobalfund.org/en/news/

News & Stories

25 April 2022

Global Fund Urges the World to Boost the Fight Against Malaria as COVID-19 Disruptions, Drug and Insecticide Resistance and New Threats Endanger Progress

   Ahead of World Malaria Day, 25 April, the Global Fund calls for renewed commitment in the fight against malaria, a disease that now kills one child every minute. After years of steady declines, malaria cases and deaths are on the rise mainly due to s…

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to  30 Apr 2022]

Latest News

News

No new digest content identified

Hilleman Laboratories   [to  30 Apr 2022]

http://www.hilleman-labs.org/

News & Insights

No new digest content identified

HHMI – Howard Hughes Medical Institute    [to  30 Apr 2022]

https://www.hhmi.org/news

Press Room                    

No new digest content identified.

Human Vaccines Project   [to  30 Apr 2022]

http://www.humanvaccinesproject.org/

News

No new digest content identified.

IAVI  [to  30 Apr 2022]

https://www.iavi.org/

Latest News

No new digest content identified.

ICRC  [to  30 Apr 2022]

https://www.icrc.org/en/whats-new

What’s New   [Selected]   

Taking COVID-19 vaccines to remote areas in Mindanao

   This is primarily because many are unable to bear the cost of travelling to a vaccine centre in the main city while others fear getting the vaccination owing to misinformation and lack of awareness.As a result, their families and communities remain v

29-04-2022 | Article

ICRC appoints a new member to governing body

   Geneva (ICRC) – At its meeting on 27 April, the Assembly of the International Committee of the Red Cross (ICRC) appointed Ms Samia Hurst-Majno as its newest member.

28-04-2022 | News release

Table of National Committees and other national bodies on international humanitarian law

26 April 2022

International Coalition of Medicines Regulatory Authorities [ICMRA]

http://www.icmra.info/drupal/en/news

Selected Statements, Press Releases, Research

No new digest content identified.

IFFIm

http://www.iffim.org/

Press Releases/Announcements

No new digest content identified.

IFRC   [to  30 Apr 2022]

http://media.ifrc.org/ifrc/news/press-releases/

Press Releases [Selected]

27/04/2022

Vaccinations vital as COVID cripples Pacific countries

    Kuala Lumpur/Suva 28 April 2022 – The International Federation of Red Cross and Red Crescent Societies are increasingly concerned for more than 1 million people in Pacific nations as they struggle with their first major wave of COVID-19 fuelled by the Omicron variants.

   Ramping up vaccinations is vital as the rapid surge in COVID infections is causing increasing death and illness in countries with low immunisation rates.

   COVID-free for almost two years, Vanuatu, the Solomon Islands, Tonga, Kiribati, and Samoa have all experienced outbreaks in their capitals, and the virus is spreading to vulnerable outer island communities which lack basic treatment and vaccination facilities.

   The virus is putting huge strains on fragile healthcare systems in population centres such as Honiara, Port Vila and Nuku’alofa. A rising number of healthcare workers are being struck down with COVID-19, further limiting health services and escalating the crisis…

26/04/2022

KwaZulu-Natal floods: Red Cross steps up response amid mounting humanitarian needs

Institut Pasteur   [to  30 Apr 2022]

https://www.pasteur.fr/en/press-area

Press Documents

No new digest content identified.

IOM / International Organization for Migration [to  30 Apr 2022]   

http://www.iom.int/press-room/press-releases

News – Selected

News  Global

29 April 2022

IOM Appeals for USD 514 Million to Support Ukraine Response

ISC / International Science Council  [to  30 Apr 2022]

https://council.science/current/

ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.

News  Blogs  Podcasts Events

Blogs

Vaccine promotion remains a key focus for this year’s Day of Immunology

29.04.2022

On this International Day of Immunology, join ISC Member the International Union of Immunological Societies (IUIS) in celebrating the theme of vaccines with promotional and educational activities.

International Union of Immunological Societies (IUIS)

Home

News/Events [Selected]

2022 International Day of Immunology

April 26, 2022

IVAC  [to  30 Apr 2022]

https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html

Updates; Events

No new digest content identified.

IVI   [to  30 Apr 2022]

http://www.ivi.int/

IVI News & Announcements

No new digest content identified.

Johns Hopkins Center for Health Security   [to  30 Apr 2022]

https://www.centerforhealthsecurity.org/news/center-news/

Center News

Johns Hopkins Center for Health Security’s COVID-19 Testing Toolkit Launches New FAQs Tool
April 28, 2022

MSF/Médecins Sans Frontières  [to  30 Apr 2022]

http://www.msf.org/

Latest [Selected Announcements]

Sudan

Violent attacks leave tens of thousands without access to healthcare in West Darfur

Project Update 29 Apr 2022

Access to medicines

“Broken” humanitarian COVID-19 vaccine system delays vaccinations

Press Release 27 Apr 2022

[See Perspectives above for detail]

National Academy of Medicine – USA  [to  30 Apr 2022]

Programs

News [Selected]

NAM to Deliver National Plan to Strengthen Health Workforce Well-Being and Restore the Health of the Nation

April 28, 2022

    The National Academy of Medicine (NAM) Action Collaborative on Clinician Well-Being and Resilience is working urgently to develop a National Plan for health workforce well-being. The draft plan will be released in May 2022 for public input and builds on almost six years of collective work among 200 Clinician Well-Being Collaborative members and network organizations. […]

National Academy of Sciences – USA  [to  30 Apr 2022]

http://www.nasonline.org/news-and-multimedia/

News

No new digest content identified.

National Vaccine Program Office – U.S. HHS  [to  30 Apr 2022]

https://www.hhs.gov/vaccines/about/index.html

Upcoming Meetings/Latest Updates                          

No new digest content identified.

NIH  [to  30 Apr 2022]

http://www.nih.gov/

News Releases 

No new digest content identified.

OECD  [to  30 Apr 2022]

http://www.oecd.org/newsroom/publicationsdocuments/bydate/

Newsroom/Library

OECD countries advancing slowly on sustainable development targets by 2030

   Despite progress made since the adoption of the 2030 Agenda for Sustainable Development and its 17 Goals (SDGs), OECD countries have met or are close to meeting only a quarter of the targets for which performance can be gauged, according to a new OECD report.

27 April 2022

PATH  [to  30 Apr 2022]                                     

https://www.path.org/media-center/

Press Releases

No new digest content identified.

Sabin Vaccine Institute  [to  30 Apr 2022]

http://www.sabin.org/updates/pressreleases

Statements and Press Releases

No new digest content identified.

UNAIDS [to  30 Apr 2022]

http://www.unaids.org/en

Selected Press Releases/Reports/Statements

28 April 2022

Key considerations to integrate HIV and mental health interventions

UNHCR Office of the United Nations High Commissioner for Refugees [to  30 Apr 2022]

http://www.unhcr.org/en-us/media-centre.htmlS

Selected News Releases, Announcements

No new digest content identified.

UNICEF  [to  30 Apr 2022]

https://www.unicef.org/media/press-releases

Press Releases, News Notes, Statements  [Selected]

Press release

04/27/2022

UNICEF and WHO warn of ‘perfect storm’ of conditions for measles outbreaks, affecting children

https://www.unicef.org/press-releases/unicef-and-who-warn-perfect-storm-conditions-measles-outbreaks-affecting-children

NEW YORK/ GENEVA, 27 April 2022 – An increase in measles cases in January and February 2022 is a worrying sign of a heightened risk for the spread of vaccine-preventable diseases and could trigger larger outbreaks, particularly of measles affecting millions of children in 2022, warn WHO and UNICEF. Pandemic-related disruptions, increasing…

[See Perspectives above for detail]

Press release

04/26/2022

Global polio eradication initiative calls for renewed commitments to achieve promise of a polio-free world

https://www.unicef.org/press-releases/global-polio-eradication-initiative-calls-renewed-commitments-achieve-promise-polio

GENEVA, 26 April 2022 – Today, the Global Polio Eradication Initiative (GPEI) announced that it is seeking new commitments to fund its 2022-2026 Strategy at a virtual event to launch its investment case. The strategy, if fully funded, will see the vaccination of 370 million children annually for the next five years and the continuation of global…

Press release

04/25/2022

1 in 4 children in Latin America and the Caribbean are exposed to diseases that can be prevented with vaccines

https://www.unicef.org/press-releases/1-4-children-latin-america-and-caribbean-are-exposed-diseases-can-be-prevented

PANAMÁ CITY, 25 April 2022 – In five years, the complete vaccination schedule for diphtheria, tetanus and pertussis (DTP3) in Latin America and the Caribbean has dropped from 90 percent in 2015 to 76 percent in 2020, according to data from the Pan American Health

[See Perspectives above for detail]

Unitaid  [to  30 Apr 2022]

Home

Featured News

No new digest content identified.

Vaccine Equity Cooperative [nee Initiative]   [to  30 Apr 2022]

News

News

No new digest content identified.

Vaccination Acceptance & Demand Initiative [Sabin)  [to  30 Apr 2022]

https://www.vaccineacceptance.org/

Announcements, Blog

World Immunization Week 2022

Working Toward a Long Life for All with Dr. Ashmita Gupta and Dr. Salvia Zeeshan!

April 26, 2022

Vaccine Confidence Project  [to  30 Apr 2022]

http://www.vaccineconfidence.org/

News, Research and Reports

No new digest content identified.

Vaccine Education Center – Children’s Hospital of Philadelphia  [to  30 Apr 2022]

http://www.chop.edu/centers-programs/vaccine-education-center

News

No new digest content identified.

Wellcome Trust  [to  30 Apr 2022]

https://wellcome.ac.uk/news

News. Opinion, Reports

No new digest content identified.

The Wistar Institute   [to  30 Apr 2022]

https://www.wistar.org/news/press-releases

Press Releases

No new digest content identified.

WFPHA: World Federation of Public Health Associations  [to  30 Apr 2022]

HOME

Latest News – Blog

No new digest content identified.

World Bank [to  30 Apr 2022]

http://www.worldbank.org/en/news/all

Selected News, Announcements

COVID-19 Vaccine Inequities and Hesitancy in Iraq

Starting in August 2020, the World Bank collaborated with the World Food Programme (WFP) and implemented nine (9) rounds of the Iraq High Frequency Phone Survey (IHFPS) as part of the WFP’s monthly mVAM…

Date: April 28, 2022 Type: Publication

World Bank, Partners Launch New Fund to Spur Smart Investments in Childcare

WASHINGTON, April 28, 2022—The World Bank and government and foundation partners today launched a new program to scale up quality, affordable childcare in developing countries – a critical investment to…

Date: April 28, 2022 Type: Press Release

Keynote Address: Breaking the Cycle of Neglect and Panic

We are meeting to discuss the issues of preparedness and response after more than two years of a global Pandemic. Although the situation has improved, we still need to be cautious given the case numbers…

Date: April 27, 2022 Type: Speeches and Transcripts

[See Week in Review above for detail]

World Customs Organization – WCO  [to  30 Apr 2022]

http://www.wcoomd.org/

Latest News

No new digest content identified.

World Organisation for Animal Health (OIE)   [to  30 Apr 2022]

https://www.oie.int/en/media/news/

Press Releases, Statements

No new digest content identified.

WTO – World Trade Organisation [to  30 Apr 2022]

http://www.wto.org/english/news_e/news_e.htm

WTO News and Events [Selected]

Members discuss improving data collection on trade in essential goods to fight COVID-19

26 April 2022

The Committee on Market Access held on 26 April the second experience-sharing session on COVID-19-related goods, with members reporting on how they have monitored and measured trade in essential goods to combat the pandemic. They also discussed ways to improve data collection at a time of crisis. In addition, members explored how to promote greater international cooperation to better track the trade flows of value chains for the manufacturing of essential COVID-19-related products.

DG Okonjo-Iweala: Trade has central role in addressing food security challenges

26 April 2022

Record food prices and a worsening food security context have given new urgency to the role of trade in addressing the challenges we face today, Director-General Okonjo-Iweala said at a seminar on food security organized by the WTO on 26 April. In her opening remarks, she said the event provided an opportunity to deepen understanding of the issues at stake and to help members take concrete steps forward so that trade can contribute to the attainment of food security around the world.

::::::

ARM [Alliance for Regenerative Medicine]  [to  30 Apr 2022]

Press Releases

Selected Press Releases

Alliance for Regenerative Medicine Announces CEO Transition

April 27, 2022   WASHINGTON, DC

   Janet Lynch Lambert will step down as the CEO of the Alliance for Regenerative Medicine after guiding the leading international advocacy organization for cell, gene and tissue-engineered therapies through five years of extraordinary growth in membership, funding, and influence. In Lambert’s time as the CEO of ARM, the membership doubled to more than 425 diverse global members and the organization’s budget and full-time staff tripled…The ARM board has constituted an 8-person Search Committee to conduct the search for a CEO successor, and Lambert is a key member of that committee. Executive search firm Catalyst Advisors, led by Partner Gilbert Forest, has been retained to support the search….

BIO    [to  30 Apr 2022]

https://www.bio.org/press-releases

Press Release

BIO Statement on USTR Special 301 Report

April 29, 2022

USTR this week released its 2022 Special 301 Report. BIO, after reviewing the report, released the following statement:

   “We welcome USTR’s efforts to address IP-related concerns for U.S.-based biotech enterprises in China, especially concerning China’s coercive technology transfer policies, patent prosecution, and patent enforcement obstacles. USTR’s emphasis on monitoring China’s progress in implementing its Phase One Agreement commitments to address these longstanding IP matters is encouraging…”

DCVMN – Developing Country Vaccine Manufacturers Network  [to  30 Apr 2022]

http://www.dcvmn.org/

News; Upcoming events

No new digest content identified.

ICBA – International Council of Biotechnology Associations   [to  30 Apr 2022]

https://internationalbiotech.org/news/

News

No new digest content identified.

IFPMA   [to  30 Apr 2022]

http://www.ifpma.org/resources/news-releases/

Selected Press Releases, Statements, Publications

Celebrating World IP Day with a focus on youth and innovation

26 April 2022

International Generic and Biosimilar Medicines Association [IGBA]

https://www.igbamedicines.org/

News

No new digest content identified.

International Alliance of Patients’ Organizations – IAPO  [to  30 Apr 2022]

https://www.iapo.org.uk/news/topic/6

Press and media [Selected]

No new digest content identified.

PhRMA    [to  30 Apr 2022]

http://www.phrma.org/

Latest News [Selected]

No new digest content identified.

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

AJOB Empirical Bioethics
Volume 13, 2022 Issue 2
https://www.tandfonline.com/toc/uabr21/current

 

Article
Ethical Reasoning During a Pandemic: Results of a Five Country European Study
S. B. Johnson, F. Lucivero, B. M. Zimmermann, E. Stendahl, G. Samuel, A. Phillips & N. Hangel
Pages: 67-78
Published online: 09 Mar 2022

AJOB Empirical Bioethics
Volume 13, 2022 Issue 2
https://www.tandfonline.com/toc/uabr21/current

 

Article
Governing Gene Drive Technologies: A Qualitative Interview Study
N. de Graeff, Karin R. Jongsma, Jeantine E. Lunshof & Annelien L. Bredenoord
Pages: 107-124
Published online: 03 Jul 2021

AMA Journal of Ethics
Volume 24, Number 4: E249-341 Apr 2022
https://journalofethics.ama-assn.org/issue/health-equity-us-latinx-communities

 

Health Equity in US Latinx Communities
Latinx communities in the US include over 60 million people with a plurality of political beliefs, cultural practices, and wealth. This diversity is also expressed in population health data: some health indicators suggest advantages of Latinx community membership while other data demonstrate inequitable disease burden and maldistribution of environmental and occupational risk. Legacies of colonial conquest of the Americas persist in discrimination and marginalization today and are embodied by members of our Latinx communities.

American Journal of Public Health
April 2022 112(52)
http://ajph.aphapublications.org/toc/ajph/current

 

Supplement 2 2022 = Global Opioid Crisis

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 30 Apr 2022)

 

Integrated delivery of family planning and childhood immunisation services: a mixed methods assessment of service responsiveness
Postpartum women represent a considerable share of the global unmet need for modern contraceptives. Evidence suggests that the integration of family planning (FP) with childhood immunisation services could hel…
Authors: Jessie K. Hamon, Misozi Kambanje, Shannon Pryor, Alice S. Kaponda, Erick Mwale, Helen E. D. Burchett, Susannah H. Mayhew and Jayne Webster
Citation: BMC Health Services Research 2022 22:572
Content type: Research Published on: 28 April 2022

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 30 Apr 2022)

 

Robustness analysis for quantitative assessment of vaccination effects and SARS-CoV-2 lineages in Italy
In Italy, the beginning of 2021 was characterized by the emergence of new variants of SARS-CoV-2 and by the availability of effective vaccines that contributed to the mitigation of non-pharmaceutical intervent…
Authors: Chiara Antonini, Sara Calandrini and Fortunato Bianconi
Citation: BMC Infectious Diseases 2022 22:415
Content type: Research Published on: 29 April 2022

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 30 Apr 2022)

 

Circulating vaccine derived polio virus type 1 outbreak, Saadah governorate, Yemen, 2020
Yemen has faced one of the worst humanitarian crises in the world since the start of the war in 2015. In 2020; 30 Vaccine Derived Polio Virus type 1 (VDPV1) isolates were detected in Saadah governorate. The ai…
Authors: Mutahar Ahmed Al-Qassimi, Mohammed Al Amad, Labiba Anam, Khaled Almoayed, Ahmed Al-Dar and Faten Ezzadeen
Citation: BMC Infectious Diseases 2022 22:414
Content type: Research Published on: 29 April 2022

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 30 Apr 2022)

 

Exploration of attitudes regarding uptake of COVID-19 vaccines among vaccine hesitant adults in the UK: a qualitative analysis
The aim of this work was to explore barriers and facilitators to uptake of COVID-19 vaccines and to explore views and reactions to efforts to improve vaccine uptake among vaccine hesitant individuals.
Authors: Sarah Denford, Fiona Mowbray, Lauren Towler, Helena Wehling, Gemma Lasseter, Richard Amlôt, Isabel Oliver, Lucy Yardley and Matthew Hickman
Citation: BMC Infectious Diseases 2022 22:407
Content type: Research Published on: 26 April 2022

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 30 Apr 2022)

 

Predictors of COVID-19 vaccine acceptability among health professions students in Vietnam
The COVID-19 vaccine hesitancy or refusal has actually been a threat to global health. In the current situation, health professions students are at risk for SARS-CoV-2 infection during their internship at heal…
Authors: Cua Ngoc Le, Uyen Thi To Nguyen and Diem Thi Hoang Do
Citation: BMC Public Health 2022 22:854
Content type: Research Published on: 28 April 2022

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 30 Apr 2022)

 

What are the reasons for refusing a COVID-19 vaccine? A qualitative analysis of social media in Germany
Vaccination against COVID-19 has been available in Germany since December 2020. However, about 30% of the population report not wanting to be vaccinated. In order to increase the willingness of the population …
Authors: Jana Fieselmann, Kübra Annac, Fabian Erdsiek, Yüce Yilmaz-Aslan and Patrick Brzoska
Citation: BMC Public Health 2022 22:846
Content type: Research Published on: 27 April 2022

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 30 Apr 2022)

 

Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County
There is substantial evidence that immunization is one of the most significant and cost-effective pillars of preventive and promotive health interventions. Effective childhood immunization coverage is thus ess…
Authors: Morris Ogero, James Orwa, Rachael Odhiambo, Felix Agoi, Adelaide Lusambili, Jerim Obure, Marleen Temmerman, Stanley Luchters and Anthony Ngugi
Citation: BMC Public Health 2022 22:826
Content type: Research article Published on: 25 April 2022

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 30 Apr 2022)

 

A tool for early estimation of influenza vaccination coverage in Spanish general population and healthcare workers in the 2018–19 season: the Gripómetro
Electronic vaccine registries are not yet widely established. There is a need to real-time monitor influenza vaccine coverage, which may raise awareness to risk groups and professionals, and eventually allow t…
Authors: Javier Díez-Domingo, Esther Redondo Margüello, Raúl Ortiz de Lejarazu Leonardo, Ángel Gil de Miguel, José María Guillén Ortega, Jesús Rincón Mora and Federico Martinón-Torres
Citation: BMC Public Health 2022 22:825
Content type: Research Published on: 25 April 2022

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 30 Apr 2022)

 

Factors related to parents’ adherence to childhood immunization
Immunizations protect children from deadly infectious diseases. Yet, there is still insufficient understanding of the factors associated with parents’ non-adherence to immunizations in contexts outside of West…
Authors: Fatimah Hobani and Eman Alhalal
Citation: BMC Public Health 2022 22:819
Content type: Research Published on: 25 April 2022

BMC Research Notes
http://www.biomedcentral.com/bmcresnotes/content
(Accessed 30 Apr 2022)

 

Improving the reproducibility and integrity of research: what can different stakeholders contribute?
Increasing awareness of problems with the reproducibility and integrity of research led the UK Parliament Science and Technology Committee to launch, in July 2021, an inquiry into reproducibility and research …
Authors: Malcolm Macleod
Citation: BMC Research Notes 2022 15:146
Content type: Commentary Published on: 25 April 2022

Clinical Pharmacology & Therapeutics
Volume 111, Issue 4 Pages: 705-971 April 2022
https://ascpt.onlinelibrary.wiley.com/toc/15326535/current

 

Therapeutic Innovations in Neuroscience
The theme of this issue of Clinical Pharmacology & Therapeutics (CPT) encompasses neuroscience in the broad sense to include neurology and psychiatry, nonclinical and clinical aspects, novel clinical trial methodologies, and modeling and simulation approaches applicable to central nervous system (CNS) drug development and therapy. While naturally the last two years have been dominated by coronavirus disease 2019 (COVID-19), it is important not to forget that drug development for other indications has not been stopped, albeit many trials were affected in terms of delays in recruitment and collection of clinical data.

Clinical Therapeutics
March 2022 Volume 44 Issue 3 p349-472
http://www.clinicaltherapeutics.com/current

 

Original Research
Rolling Reviews During COVID-19: The European Union Experience in a Global Context
Roelie Marinus, Sarah Mofid, Marya Mpandzou, Thomas C. Kühler
Published online: January 09, 2022
p352-363
Open Access

Clinical Therapeutics
March 2022 Volume 44 Issue 3 p349-472
http://www.clinicaltherapeutics.com/current

 

Reviews
Real-World Evidence for Regulatory Decision-Making: Guidance From Around the World
Leah Burns, Nadege Le Roux, Robert Kalesnik-Orszulak,…Mathias Hukkelhoven, Frank Rockhold, John O’Donnell
Published online: February 15, 2022
p420-437
Open Access

Clinical Therapeutics
March 2022 Volume 44 Issue 3 p349-472
http://www.clinicaltherapeutics.com/current

 

Commentaries
Beyond Influenza Vaccination: Expanding Infrastructure for Hospital-based Pediatric COVID-19 Vaccine Delivery
Annika M. Hofstetter, Suchitra Rao, Ravi Jhaveri
Published online: January 26, 2022
p450-455

Global Health: Science and Practice (GHSP)
Vol. 10, No. 2 April 28, 2022
http://www.ghspjournal.org/content/current

 

COMMENTARIES
Open Access
End Malaria Faster: Taking Lifesaving Tools Beyond “Access” to “Reach” All People in Need
Courtney Emerson, Jed Meline, Anne Linn, Julie Wallace, Bryan K. Kapella, Meera Venkatesan and Richard Steketee
Global Health: Science and Practice April 2022, 10(2):e2200118; https://doi.org/10.9745/GHSP-D-22-00118
To “reach the unreached” with preventive and curative malaria services, we must know which individuals and communities remain unreached and then bring tailored services from the clinic to the community and home.

Global Health: Science and Practice (GHSP)
Vol. 10, No. 2 April 28, 2022
http://www.ghspjournal.org/content/current

 

Community Health Workers in Pandemics: Evidence and Investment Implications
Madeleine Ballard, Ari Johnson, Iris Mwanza, Hope Ngwira, Jennifer Schechter, Margaret Odera, Dickson Nansima Mbewe, Roseline Moenga, Prossy Muyingo, Ramatulai Jalloh, John Wabwire, Angela Gichaga, Nandini Choudhury, Duncan Maru, Pauline Keronyai, Carey Westgate, Sabitri Sapkota, Helen Elizabeth Olsen, Kyle Muther, Stephanie Rapp, Mallika Raghavan, Kim Lipman-White, Matthew French, Harriet Napier and Lyudmila Nepomnyashchiy
Global Health: Science and Practice April 2022, 10(2):e2100648; https://doi.org/10.9745/GHSP-D-21-00648
Community health workers have long played a critical role in preventing, detecting, and responding to pandemics across the globe. To expand, improve, and institutionalize these services, changes in the approach to bi/multilateral aid and private philanthropic investments in low- and middle-income countries are required.

Global Health: Science and Practice (GHSP)
Vol. 10, No. 2 April 28, 2022
http://www.ghspjournal.org/content/current

 

VIEWPOINTS
Open Access
Strategies to Promote Health System Strengthening and Global Health Security at the Subnational Level in a World Changed by COVID-19
Martin Alilio, Neetu Hariharan, Elizabeth Lugten, Kama Garrison, Rhea Bright, Wilberforce Owembabazi, Uwem Inyang, Saad El-Din Hassan and Kelly Saldana
Global Health: Science and Practice April 2022, 10(2):e2100478; https://doi.org/10.9745/GHSP-D-21-00478
Structural weaknesses in national health systems have led to huge variations in responses to COVID-19. This calls for a unified approach to health security and essential health services as public health threats and the expectation for health care systems to provide improved access and services at affordable cost increases.

Global Health: Science and Practice (GHSP)
Vol. 10, No. 2 April 28, 2022
http://www.ghspjournal.org/content/current

 

ORIGINAL ARTICLES
Open Access
Cost of Delivering Tetanus Toxoid and Tetanus-Diphtheria Vaccination in Vietnam and the Budget Impact of Proposed Changes to the Schedule
Vu Quynh Mai, Laura Boonstoppel, Kelsey Vaughan, Carl Schutte, Annette Ozaltin, Duong Thi Hong, Nguyen Mai Khanh, Hoang Manh Thang, Tran Tuan Anh and Hoang Van Minh
Global Health: Science and Practice April 2022, 10(2):e2100482; https://doi.org/10.9745/GHSP-D-21-00482
This study shows that replacing tetanus toxoid vaccination in Vietnam for girls aged 15–16 years in high-risk areas with routine tetanus-diphtheria vaccination for children aged 7 years mainly through a school-based delivery strategy will likely result in immunization cost savings.

Global Public Health
Volume 17, Issue 5 (2022)
http://www.tandfonline.com/toc/rgph20/current

 

Review Article
What makes global healthcare partnerships successful? A systematic review
Regan Guilfoyle, Alexander D. Morzycki & Abdullah Saleh
Pages: 662-671
Published online: 09 Mar 2021
ABSTRACT
Academic communities are increasingly involved in efforts to address the overwhelming burden of disease in low-middle income countries. There is, however, little research dedicated to understanding the best approach to creating a successful and sustainable global healthcare project. Our objective was to review the shared characteristics of successful healthcare partnerships between high- and low-middle income countries. Two independent reviewers conducted a systematic review. Articles, describing collaborative, healthcare partnerships between a high- and low-middle income countries between 1910 and September 2018, were included. Twenty-six articles were included. The majority of collaborations were initiated by either the host institution or as a joint decision between institutions. The primary goal of these collaborations revolved around medical education/training and curriculum development. Two partnerships, after more than a decade of collaboration, had achieved a self-sustaining programme. Lack of funding was identified as a major barrier to sustainability. Successful global healthcare partnerships require true collaboration and equal participation of all partners. Funding should be secured prior to programme development in anticipation of a minimum 10-year project. A minimum list of guidelines has been proposed to improve the chances of both a successful and sustainable collaboration.

Health Policy and Planning
Volume 37, Issue 4, April 2022
https://academic.oup.com/heapol/issue/37/4

 

REVIEWS
Seroprevalence and risk factors of COVID-19 in healthcare workers from 11 African countries: a scoping review and appraisal of existing evidence
Sophie Alice Müller, Rebekah Ruth Wood, Johanna Hanefeld, Charbel El-Bcheraoui
Health Policy and Planning, Volume 37, Issue 4, April 2022, Pages 505–513, https://doi.org/10.1093/heapol/czab133

Health Policy and Planning
Volume 37, Issue 4, April 2022
https://academic.oup.com/heapol/issue/37/4

 

A systematic review of scope and quality of health economic evaluations conducted in Ethiopia
Daniel Erku, Amanual G Mersha, Eskinder Eshetu Ali, Gebremedhin B Gebretekle, Befikadu L Wubishet
Health Policy and Planning, Volume 37, Issue 4, April 2022, Pages 514–522, https://doi.org/10.1093/heapol/czac005

Health Policy and Planning
Volume 37, Issue 4, April 2022
https://academic.oup.com/heapol/issue/37/4

 

What makes working together work? A scoping review of the guidance on North–South research partnerships
Shirine Voller, Joanna Schellenberg, Primus Chi, Nicki Thorogood
Health Policy and Planning, Volume 37, Issue 4, April 2022, Pages 523–534, https://doi.org/10.1093/heapol/czac008

International Journal of Human Rights in Healthcare
Volume 15 Issue 2, 2022
https://www.emerald.com/insight/publication/issn/2056-4902/vol/15/iss/2

 

Table of Contents
The role of social media in promoting citizenship values of international students during the COVID-19 global health crisis
Thelal Iqab Oweis
The purpose of this study, accordingly, is to not only offer insights about Arab international students’ stress management and adjustment mechanisms while abroad but also bring to light the extent to which these digital citizens’ use of social media networks reinforces their citizenship values and preserves their national identity during the COVID-19 global health crisis.

JAMA
April 26, 2022, Vol 327, No. 16, Pages 1527-1624
https://jamanetwork.com/journals/jama/currentissue

 

Research Letter
Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households
Silje B. Jørgensen, MD, PhD; Karin Nygård, PhD; Oliver Kacelnik, MD, PhD; et al.
free access has active quiz
JAMA. 2022;327(16):1610-1611. doi:10.1001/jama.2022.3780
This nationwide registry data study from Norway assesses the secondary attack rate of SARS-CoV-2 variants Delta and Omicron in an effort to estimate the transmissibility of the Omicron variant.

JAMA
April 26, 2022, Vol 327, No. 16, Pages 1527-1624
https://jamanetwork.com/journals/jama/currentissue

 

Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel
Limor Friedensohn, MD; Dan Levin, MD; Maggie Fadlon-Derai, MHA; et al.
free access has active quiz
JAMA. 2022;327(16):1611-1612. doi:10.1001/jama.2022.4425
This study assessed whether a third vaccine dose was associated with the risk of myocarditis among military personnel in Israel.

JAMA
April 26, 2022, Vol 327, No. 16, Pages 1527-1624
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Attacks on Health Care in the War in UkraineInternational Law and the Need for Accountability
Lawrence O. Gostin, JD; Leonard S. Rubenstein, JD
free access has audio
JAMA. 2022;327(16):1541-1542. doi:10.1001/jama.2022.6045
This Viewpoint from Gostin and Rubenstein examine the violence against health care workers and institutions in the war in Ukraine and potential paths to hold those perpetuating such attacks accountable.
JAMA Medical News Audio: Ukrainian Doctors Share Current Experiences
Editorial
Catastrophic Health Consequences of the War in Ukraine
Phil B. Fontanarosa, MD, MBA; Annette Flanagin, RN, MA; Robert M. Golub, MD

JAMA
April 26, 2022, Vol 327, No. 16, Pages 1527-1624
https://jamanetwork.com/journals/jama/currentissue

 

Medical News & Perspectives
Clinical Trials Disrupted During War in Ukraine
Rita Rubin, MA
free access has audio
JAMA. 2022;327(16):1535-1536. doi:10.1001/jama.2022.5571
This Medical News feature describes how the Russian invasion has disrupted clinical trials in Ukraine as well as Russia.

JAMA Network
COVID-19 Update April 30, 2022

 

These articles on COVID-19 were published across the JAMA Network in the last week.

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 30 Apr 2022]

 

COVID-19 vaccines: awareness, attitude and acceptance among undergraduate University students
The myths and conspiracy theories on the COVID-19 vaccine cause people to be hesitant and maleficent towards the vaccine.
Authors: Firew Asres and Belachew Umeta
Citation: Journal of Pharmaceutical Policy and Practice 2022 15:32
Content type: Research Published on: 26 April 2022

The Lancet
Apr 30, 2022 Volume 399 Number 10336 p1669-1752, e39-e41
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial
Trong Toan Nguyen, et al.

The Lancet
Apr 30, 2022 Volume 399 Number 10336 p1669-1752, e39-e41
https://www.thelancet.com/journals/lancet/issue/current

 

Series
Optimising Child and Adolescent Health and Development
Health and development from preconception to 20 years of age and human capital
Robert E Black, et al.

The Lancet
Apr 30, 2022 Volume 399 Number 10336 p1669-1752, e39-e41
https://www.thelancet.com/journals/lancet/issue/current

 

Optimising Child and Adolescent Health and Development
Effects of early-life poverty on health and human capital in children and adolescents: analyses of national surveys and birth cohort studies in LMICs
Cesar G Victora, et al.

Nature
Volume 604 Issue 7907, 28 April 2022
https://www.nature.com/nature/volumes/604/issues/7907

 

Article | 07 March 2022 | Open Access
SARS-CoV-2 is associated with changes in brain structure in UK Biobank
Gwenaëlle Douaud, Soojin Lee, Stephen M. Smith
After infection with SARS-CoV-2, individuals show a greater reduction in grey matter thickness and tissue contrast in the orbitofrontal cortex and parahippocampal gyrus; greater changes in markers of tissue damage in regions that are functionally connected to the primary olfactory cortex; and a greater reduction in global brain size.

Nature
Volume 604 Issue 7907, 28 April 2022
https://www.nature.com/nature/volumes/604/issues/7907

 

Article
Climate change increases cross-species viral transmission risk
Colin J. Carlson, et al.
Published: 28 April 2022
Abstract
At least 10,000 virus species have the capacity to infect humans, but at present, the vast majority are circulating silently in wild mammals1,2. However, climate and land use change will produce novel opportunities for viral sharing among previously geographically-isolated species of wildlife3,4. In some cases, this will facilitate zoonotic spillover—a mechanistic link between global environmental change and disease emergence. Here, we simulate potential hotspots of future viral sharing, using a phylogeographic model of the mammal-virus network, and projections of geographic range shifts for 3,139 mammal species under climate change and land use scenarios for the year 2070. We predict that species will aggregate in new combinations at high elevations, in biodiversity hotspots, and in areas of high human population density in Asia and Africa, driving the novel cross-species transmission of their viruses an estimated 4,000 times. Because of their unique dispersal capacity, bats account for the majority of novel viral sharing, and are likely to share viruses along evolutionary pathways that will facilitate future emergence in humans. Surprisingly, we find that this ecological transition may already be underway, and holding warming under 2 °C within the century will not reduce future viral sharing. Our findings highlight an urgent need to pair viral surveillance and discovery efforts with biodiversity surveys tracking species’ range shifts, especially in tropical regions that harbor the most zoonoses and are experiencing rapid warming.

New England Journal of Medicine
April 28, 2022 Vol. 386 No. 17
https://www.nejm.org/toc/nejm/medical-journal

 

Original Articles
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting O. Magen and Others

New England Journal of Medicine
April 28, 2022 Vol. 386 No. 17
https://www.nejm.org/toc/nejm/medical-journal

 

Review Article
Understanding Vaccine Safety and the Roles of the FDA and the CDC H.C. Meissner

New England Journal of Medicine
April 28, 2022 Vol. 386 No. 17
https://www.nejm.org/toc/nejm/medical-journal

 

Editorials
Covid-19 Boosters — Where from Here? P.A. Offit
n December 10, 2020, Pfizer presented results from a 36,000-person, two-dose, prospective, placebo-controlled trial of its Covid-19 messenger RNA (mRNA) vaccine, BNT162b2, to the Food and Drug Administration (FDA).¹ The vaccine was 95% effective at preventing severe illness in all age groups, independent of coexisting conditions or racial or ethnic background. A remarkable result. Six months later, studies showed that protection against severe disease was holding up.² The results of these epidemiologic studies were consistent with those of immunologic studies showing long-lived, high frequencies of Covid-19–specific memory B and T cells, which mediate protection against severe disease.³

In September 2021, 10 months after the BNT162b2 vaccine had become available, Israeli researchers found that protection against severe illness in people 60 years of age or older was enhanced by a third dose.⁴ In response, the Centers for Disease Control and Prevention (CDC) recommended that people 65 years of age or older should receive three doses of an mRNA vaccine.

In a study now reported in the Journal,⁵ Israeli researchers found that in a study population with a median age of 72 years, protection against severe disease was further enhanced by a fourth dose of mRNA vaccine during the wave of infections caused by the B.1.1.529 (omicron) variant of SARS-CoV-2. These findings were considered by the FDA and CDC in their decision-making process regarding the use of an additional booster dose of mRNA vaccine for people 50 years of age or older.

What about booster dosing for persons who are younger? One year after the BNT162b2 vaccine became available, studies in the United States showed that a third dose of vaccine also enhanced protection against severe disease for people as young as 18 years of age.6,7 Unfortunately, these studies did not stratify patients according to whether they had coexisting conditions. Therefore, it was unclear who among these younger age groups most benefited from an additional dose. Nonetheless, the CDC later recommended that everyone 12 years of age or older should receive three doses of BNT162b2, regardless of whether risk factors were present. This universal booster recommendation led some summer camps, high schools, universities, hospitals, and businesses to require three doses of mRNA vaccine. In February 2022, in a study that did not support the booster recommendation for children, CDC researchers found that two doses of BNT162b2 induced long-lived protection against serious illness in children 12 to 18 years of age.⁸

In addition to protection against severe disease, the initial phase 3 trial of BNT162b2 — which was performed over a period of several months — also showed 95% protection against mild illness.¹ Unlike protection against severe illness, however, protection against mild illness, which is mediated by high titers of virus-specific neutralizing antibodies at the time of exposure, declined after 6 months, as would have been expected.² In response, studies by Pfizer were published in which a booster dose was shown to restore protection against mild illness⁹; unfortunately, this protection did not persist for more than a few months.⁶ Short-lived protection against mild illness will limit the ability of booster dosing to lessen transmission.

People are now confused about what it means to be fully vaccinated. It is easy to understand how this could happen. Arguably, the most disappointing error surrounding the use of Covid-19 vaccines was the labeling of mild illnesses or asymptomatic infections after vaccination as “breakthroughs.” As is true for all mucosal vaccines, the goal is to protect against serious illness — to keep people out of the hospital, intensive care unit, and morgue. The term “breakthrough,” which implies failure, created unrealistic expectations and led to the adoption of a zero-tolerance strategy for this virus. If we are to move from pandemic to endemic, at some point we are going to have to accept that vaccination or natural infection or a combination of the two will not offer long-term protection against mild illness.

In addition, because boosters are not risk-free, we need to clarify which groups most benefit. For example, boys and men between 16 and 29 years of age are at increased risk for myocarditis caused by mRNA vaccines.¹⁰ And all age groups are at risk for the theoretical problem of an “original antigenic sin” — a decreased ability to respond to a new immunogen because the immune system has locked onto the original immunogen. An example of this phenomenon can be found in a study of nonhuman primates showing that boosting with an omicron-specific variant did not result in higher titers of omicron-specific neutralizing antibodies than did boosting with the ancestral strain.¹¹ This potential problem could limit our ability to respond to a new variant.

It is now incumbent on the CDC to determine who most benefits from booster dosing and to educate the public about the limits of mucosal vaccines. Otherwise, a zero-tolerance strategy for mild or asymptomatic infection, which can be implemented only with frequent booster doses, will continue to mislead the public about what Covid-19 vaccines can and cannot do.

PLoS Biology
https://journals.plos.org/plosbiology/
(Accessed 30 Apr 2022)

 

One step closer to a transmissible vaccine for rabies virus
Scott L. Nuismer
Primer | published 20 Apr 2022 PLOS Biology
https://doi.org/10.1371/journal.pbio.3001607

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 30 Apr 2022)

 

Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis
Benjamin Speich, Dmitry Gryaznov, Jason W. Busse, Viktoria L. Gloy, Szimonetta Lohner, Katharina Klatte, Ala Taji Heravi, Nilabh Ghosh, Hopin Lee, Anita Mansouri, Ioana R. Marian, Ramon Saccilotto, Edris Nury, Benjamin Kasenda, Elena Ojeda–Ruiz, Stefan Schandelmaier, Yuki Tomonaga, Alain Amstutz, Christiane Pauli–Magnus, Karin Bischoff, Katharina Wollmann, Laura Rehner, Joerg J. Meerpohl, Alain Nordmann, Jacqueline Wong, Ngai Chow, Patrick Jiho Hong, Kimberly Mc Cord – De Iaco, Sirintip Sricharoenchai, Arnav Agarwal, Matthias Schwenkglenks, Lars G. Hemkens, Erik von Elm, Bethan Copsey, Alexandra N. Griessbach, Christof Schönenberger, Dominik Mertz, Anette Blümle, Belinda von Niederhäusern, Sally Hopewell, Ayodele Odutayo, Matthias Briel
Research Article | published 27 Apr 2022 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003980

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 30 Apr 2022)

 

Social justice now for an equitable tomorrow: Reflections from the Consortium of Universities for Global Health Conference 2022
Beryne Odeny, Callam Davidson
Perspective | published 22 Apr 2022 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003995

PLoS One
http://www.plosone.org/
[Accessed 30 Apr 2022]

 

Research Article
Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods
Cleo Anastassopoulou, Dimitra Antoni, Yiannis Manoussopoulos, Panagiotis Stefanou, Sofia Argyropoulou, Georgia Vrioni, Athanasios Tsakris
Research Article | published 29 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0266958

PLoS One
http://www.plosone.org/
[Accessed 30 Apr 2022]

 

Human drone interaction in delivery of medical supplies: A scoping review of experimental studies
Franziska Stephan, Nicole Reinsperger, Martin Grünthal, Denny Paulicke, Patrick Jahn
Research Article | published 28 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0267664

PLoS One
http://www.plosone.org/
[Accessed 30 Apr 2022]

 

Vaccination against misinformation: The inoculation technique reduces the continued influence effect
Mikołaj Buczel, Paulina D. Szyszka, Adam Siwiak, Malwina Szpitalak, Romuald Polczyk
Research Article | published 28 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0267463

PLoS One
http://www.plosone.org/
[Accessed 30 Apr 2022]

 

Responsiveness of open innovation to COVID-19 pandemic: The case of data for good
Francesco Scotti, Francesco Pierri, Giovanni Bonaccorsi, Andrea Flori
Research Article | published 26 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0267100